| P50 | author | Steve Ward | Q55112735 |
| | Makandwe Nyirenda | Q56856504 |
| | Hannah Blencowe | Q58226589 |
| | Giancarlo Biagini | Q41938978 |
| P2093 | author name string | Stephan Duparc | |
| | Malcolm Molyneux | |
| | Peter A Winstanley | |
| | Hyginus Opara | |
| | Daniel G Wootton | |
| | Colin Neate | |
| | Mary Woessner | |
| | Sam Dunyo | |
| | Paula L Kirby | |
| | Maxwell K Kanjala | |
| | Queen Dube-Mbeye | |
| | Thomas Kanyok | |
| P2860 | cites work | Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa | Q24810617 |
| | Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum | Q31389858 |
| | Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives | Q33646966 |
| | Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria | Q33929311 |
| | Oral artesunate dose-response relationship in acute falciparum malaria | Q34113505 |
| | Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon | Q34734703 |
| | Drug-resistant malaria | Q36248426 |
| | Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes | Q37568641 |
| | Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial | Q38870092 |
| | Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. | Q38883375 |
| | Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi | Q40486195 |
| | Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria | Q40642165 |
| | The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency | Q40656977 |
| | Concentration and time dependency of artemisinin efficacy against Plasmodium falciparum in vitro. | Q41935235 |
| | Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria | Q43796087 |
| | Artemisinin (qinghaosu)--a new gametocytocidal drug for malaria | Q44147893 |
| | Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 |
| | Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial | Q44185167 |
| | 5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children. | Q46545290 |
| | Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine. | Q46597626 |
| | Effects of artemisinin derivatives on malaria transmissibility | Q48027455 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| | Plasmodium falciparum | Q311383 |
| | artesunate | Q707939 |
| | Plasmodium falciparum malaria | Q18554672 |
| P304 | page(s) | e1779 | |
| P577 | publication date | 2008-03-05 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria | |
| P478 | volume | 3 | |